Last reviewed · How we verify
Glasdegib IV infusion
Glasdegib IV infusion is a Small molecule drug developed by Pfizer. It is currently in Phase 1 development.
At a glance
| Generic name | Glasdegib IV infusion |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Nausea
- Febrile neutropenia
- Anaemia
- Diarrhoea
- Pyrexia
- Platelet count decreased
- Hypokalaemia
- Constipation
- Neutrophil count decreased
- White blood cell count decreased
- Vomiting
- Thrombocytopenia
Key clinical trials
- Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia (PHASE2)
- Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML (PHASE3)
- A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia (PHASE3)
- GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia (PHASE2)
- Glasdegib Absolute Bioavailability Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glasdegib IV infusion CI brief — competitive landscape report
- Glasdegib IV infusion updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Glasdegib IV infusion
What is Glasdegib IV infusion?
Glasdegib IV infusion is a Small molecule drug developed by Pfizer.
Who makes Glasdegib IV infusion?
Glasdegib IV infusion is developed by Pfizer (see full Pfizer pipeline at /company/pfizer).
What development phase is Glasdegib IV infusion in?
Glasdegib IV infusion is in Phase 1.
What are the side effects of Glasdegib IV infusion?
Common side effects of Glasdegib IV infusion include Nausea, Febrile neutropenia, Anaemia, Diarrhoea, Pyrexia, Platelet count decreased.
Related
- Manufacturer: Pfizer — full pipeline
- Compare: Glasdegib IV infusion vs similar drugs
- Pricing: Glasdegib IV infusion cost, discount & access